These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24720467)

  • 21. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
    Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
    Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.
    Contopoulos-Ioannidis DG; O'Brien TR; Goedert JJ; Rosenberg PS; Ioannidis JP
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):70-6. PubMed ID: 12514416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chemokine receptor 5 delta32 polymorphism and type 1 diabetes, Behcet's disease, and asthma: a meta-analysis.
    Song GG; Kim JH; Lee YH
    Immunol Invest; 2014; 43(2):123-36. PubMed ID: 24171669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
    Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
    Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis.
    Silva-Carvalho WH; de Moura RR; Coelho AV; Crovella S; Guimarães RL
    Infect Genet Evol; 2016 Sep; 43():101-7. PubMed ID: 27208805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
    Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
    AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR5-Δ32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes.
    Słomiński B; Ławrynowicz U; Ryba-Stanisławowska M; Skrzypkowska M; Myśliwska J; Myśliwiec M
    Cytokine; 2019 Feb; 114():81-85. PubMed ID: 30420202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR5-Δ32 gene polymorphism is associated with retinopathy in patients with type 1 diabetes.
    Słomiński B; Ławrynowicz U; Myśliwska J; Ryba-Stanisławowska M; Skrzypkowska M; Brandt A
    Mol Cell Endocrinol; 2017 Jan; 439():256-260. PubMed ID: 27619405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR5-Delta32 polymorphism and susceptibility to cervical cancer: association with early stage of cervical cancer.
    Singh H; Sachan R; Jain M; Mittal B
    Oncol Res; 2008; 17(2):87-91. PubMed ID: 18543610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.
    Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA
    Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.
    Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Schirin-Sokhan R; Gartung C; Lorenzen J; Matern S; Lammert F
    J Mol Med (Berl); 2004 Jan; 82(1):64-9. PubMed ID: 14673528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of CCR5-Δ32 deletion on C-reactive protein levels and cardiovascular disease: Results from the Danish Blood Donor Study.
    Dinh KM; Pedersen OB; Petersen MS; Sørensen E; Sørensen CJ; Kaspersen KA; Larsen MH; Møller B; Hjalgrim H; Ullum H; Erikstrup C
    Atherosclerosis; 2015 Sep; 242(1):222-5. PubMed ID: 26222902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease.
    Atzeni F; Boiardi L; Casali B; Farnetti E; Nicoli D; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C
    Rheumatology (Oxford); 2012 Dec; 51(12):2141-5. PubMed ID: 22966075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.
    op den Dries S; Buis CI; Adelmeijer J; Van der Jagt EJ; Haagsma EB; Lisman T; Porte RJ
    Liver Int; 2011 Sep; 31(8):1102-9. PubMed ID: 21134114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
    Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
    Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The case for selection at CCR5-Delta32.
    Sabeti PC; Walsh E; Schaffner SF; Varilly P; Fry B; Hutcheson HB; Cullen M; Mikkelsen TS; Roy J; Patterson N; Cooper R; Reich D; Altshuler D; O'Brien S; Lander ES
    PLoS Biol; 2005 Nov; 3(11):e378. PubMed ID: 16248677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the chemokine receptor CCR5 in the development of American cutaneous leishmaniasis in a Southern Brazilian population.
    Ribas AD; Ribas RC; Da Silva Júnior WV; Aristides SM; Lonardoni MV; Watanabe MA; Borelli SD; Silveira TG
    Mol Med Rep; 2013 Jul; 8(1):189-94. PubMed ID: 23632983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CCR5 Delta32 bp deletion in RA and SLE.
    Martens HA; Kallenberg CG; Bijl M
    Autoimmunity; 2009 May; 42(4):260-2. PubMed ID: 19811270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of chemokines receptor (CCR5 Delta32) in idiopathic recurrent miscarriages among north Indians.
    Parveen F; Tripathi G; Singh B; Agrawal S
    Arch Gynecol Obstet; 2009 Aug; 280(2):229-34. PubMed ID: 19116725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.